Browsing by Author Creese, B
Showing results 27 to 46 of 60
< previous
next >
| Issue Date | Title | Author(s) |
|---|---|---|
| 24-May-2024 | Late-life onset psychosis-like symptoms assessed in the Mild Behavioural Impairment framework are associated with impaired performance on the Stroop task | Creese, B; Gibbs, O; Moodie, E; Hampshire, A; Corbett, A; Ismail, Z |
| 4-Jan-2022 | Latent subtypes of manic and/or irritable episode symptoms in two population-based cohorts | Arathimos, R; Fabbri, C; Vassos, E; Davis, KAS; Pain, O; Gillett, A; Coleman, JRI; Hanscombe, K; Hagenaars, S; Jermy, B; Corbett, A; Ballard, C; Aarsland, D; Creese, B; Lewis, CM |
| 18-Aug-2025 | Leveraging multiomic approaches to elucidate mechanisms of heterogeneity in Alzheimer’s disease: neuropsychiatric symptoms, co-pathologies, and sex differences | Shwab, EK; Pathak, G; Harvey, J; Belloy, ME; Fischer, CE; Lutz, MW; Scholz, SW; Cook, N; Reid, DM; Chen, J; Guan, DX; Oliveira, F; Sinclair, LI; Imo, U; Creese, B; Chiba-Falek, O |
| 27-Jan-2023 | Lifetime Traumatic Brain Injury and Cognitive Domain Deficits in Late Life: The PROTECT-TBI Cohort Study | Lennon, MJ; Brooker, H; Creese, B; Thayanandan, T; Rigney, G; Aarsland, D; Hampshire, A; Ballard, C; Corbett, A; Raymont, V |
| 4-Oct-2024 | Linking cognitive and behavioral reserve: Evidence from the CAN-PROTECT study | Guan, DX; Mortby, ME; Pike, GB; Ballard, C; Creese, B; Corbett, A; Pickering, E; Hampshire, A; Roach, P; Smith, EE; Ismail, Z |
| 18-Apr-2023 | A longitudinal study of late-life psychosis and incident dementia and the potential effects of race and cognition | Ismail, Z; Ghahremani, M; Amlish Munir, M; Fischer, CE; Smith, EE; Creese, B |
| 7-Nov-2022 | Machine learning-based prediction of cognitive outcomes in de novo Parkinson’s disease | Harvey, J; Reijnders, RA; Cavill, R; Duits, A; Köhler, S; Eijssen, L; Rutten, BPF; Shireby, G; Torkamani, A; Creese, B; Leentjens, AFG; Lunnon, K; Pishva, E |
| 25-Dec-2025 | The measurement of agitation in neurocognitive disorders: A systematic review | Guan, DX; Creese, B; Germain, CM; Fischer, CE; Kossowska-Kuhn, D; Ferreira de Oliveira, F; Wang, HJJ; Umapathy, K; Lanctôt, KL; Sinclair, LI; Agüera-Ortiz, L; Pinheiro Nepomuceno, M; Bruneau, M-A; Mortby, ME; Bishnoi, RJ; Machado Castilhos, R; Sud, R; Loi, SM; Atunwa, SA; Pan, TJ; Saari, TT; Imo, U; Ucheagwu, VA; Ismail, Z; Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment (ISTAART) Agitation work group |
| 5-Mar-2025 | Menopausal symptom burden as a predictor of mid- to late-life cognitive function and mild behavioral impairment symptoms: A CAN-PROTECT study | Crockford, JFE; Guan, DX; Einstein, G; Ballard, C; Creese, B; Corbett, A; Pickering, E; Bloomfield, A; Roach, P; Smith, EE; Ismail, Z |
| 21-Nov-2023 | Microglial activation, tau and amyloid deposition in TREM2 p.R47H carriers and mild cognitive impairment patients: a multi-modal/multi-tracer PET/MRI imaging study with influenza vaccine immune challenge | Cousins, O; Schubert, JJ; Chandra, A; Veronese, M; Valkimadi, P; Creese, B; Khan, Z; Arathimos, R; Hampshire, A; Rosenzweig, I; Ballard, C; Corbett, A; Aasland, D; Velayudhan, L; O’Neill, M; Collier, D; Awais, R; Sander, K; Årstad, E; Howes, O; Turkheimer, F; Hodges, A |
| 30-Sep-2024 | Mild Behavioral Impairment and Quality of Life in Community Dwelling Older Adults | Warring, I; Guan, D; Ballard, C; Creese, B; Corbett, A; Pickering, E; Roach, P; Smith, EE; Ismail, Z |
| 5-Jan-2022 | Mild behavioral impairment: measurement and clinical correlates of a novel marker of preclinical Alzheimer’s disease | Creese, B; Ismail, Z |
| 22-Jun-2024 | The mind and motion: exploring the interplay between physical activity and Mild Behavioral Impairment in dementia-free older adults | Mudalige, D; Guan, DX; Ballard, C; Creese, B; Corbett, A; Pickering, E; Roach, P; Smith, EE; Ismail, Z |
| 29-Jul-2023 | Optimizing detection of Alzheimer’s disease in mild cognitive impairment: a 4-year biomarker study of mild behavioral impairment in ADNI and MEMENTO | Ismail, Z; Leon, R; Creese, B; Ballard, C; Robert, P; Smith, EE |
| 28-Jan-2025 | Oral microbiome and nitric oxide biomarkers in older people with mild cognitive impairment and APOE4 genotype | L’Heureux, JE; Corbett, A; Ballard, C; Vauzour, D; Creese, B; Winyard, PG; Jones, AM; Vanhatalo, A |
| 24-Nov-2025 | Plasma biomarkers in neuropsychiatric syndromes: A narrative review | Ismail, Z; Guan, DX; Babulal, GM; Bateman, JR; Cantillon, M; Creese, B; D'Antonio, F; Fischer, CE; Gatchel, JR; Ghahremani, M; Guerrero-Cantera, J; Lanctôt, KL; Mielke, MM; Mortby, ME; Feldman, O; Pereira, AC; Pereiro, AX; Perry, G; Potter, WZ; Rabl, M; Ravona-Springer, R; Rosen, AC; Rouse, HJ; Sankhe, K; Schindler, SE; Udeh-Momoh, CT; Tarawneh, R; Ferreira de Oliveira, F; Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART), Biofluid Based Biomarkers in Neuropsychiatric Syndromes work group |
| 11-Nov-2020 | Polygenic Risk Scoring is an Effective Approach to Predict Those Individuals Most Likely to Decline Cognitively Due to Alzheimer’s Disease | Daunt, P; Ballard, CG; Creese, B; Davidson, G; Hardy, J; Oshota, O; Pither, RJ; Gibson, AM |
| 13-Jun-2025 | Pre-psychosis in later life as a risk factor for progressive cognitive decline: Findings from the IPA psychosis in neurodegenerative disease working group | Creese, B; Cummings, J; Fischer, C; Jeste, D; Ikeda, M; Mills, K; Ismail, Z; Ballard, C |
| 9-Jan-2025 | Predicting individual‐level stroke risk associated with risperidone use in dementia using cardiovascular disease history: matched UK population based cohort study | Choma, NJ; Griffiths, A; Henley, WE; Mueller, C; Williams, N; Dennis, J; Creese, B |
| 21-Dec-2023 | Proof-of-concept recall-by-genotype study of extremely low and high Alzheimer’s polygenic risk reveals autobiographical deficits and cingulate cortex correlates | Lancaster, T; Creese, B; Escott-Price, V; Driver, I; Menzies, G; Khan, Z; Corbett, A; Ballard, C; Williams, J; Murphy, K; Chandler, H |